These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10972178)

  • 41. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transduction of specific inhibition of HuT 78 human T cell chemotaxis by type I vasoactive intestinal peptide receptors.
    Xia M; Gaufo GO; Wang Q; Sreedharan SP; Goetzl EJ
    J Immunol; 1996 Aug; 157(3):1132-8. PubMed ID: 8757618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Importance of the vasoactive intestinal peptide receptor in the stimulation of cyclic adenosine 3',5'-monophosphate in gallbladder epithelial cells of man. Comparison with the guinea pig.
    Dupont C; Broyart JP; Broer Y; Chenut B; Laburthe M; Rosselin G
    J Clin Invest; 1981 Mar; 67(3):742-52. PubMed ID: 6259209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
    Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
    Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The autocrine function of vasoactive intestinal peptide on human neuroblastoma cell growth and differentiation.
    Pence JC; Shorter NA
    Arch Surg; 1993 May; 128(5):591-5. PubMed ID: 8387768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
    Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
    Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Somatostatin inhibits vasoactive intestinal peptide-stimulated cyclic adenosine monophosphate accumulation in GH pituitary cells.
    Dorflinger LJ; Schonbrunn A
    Endocrinology; 1983 Nov; 113(5):1541-50. PubMed ID: 6194974
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
    Delgado M; Ganea D
    J Immunol; 2001 Jan; 166(2):1028-40. PubMed ID: 11145682
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased binding of vasoactive intestinal peptide to intestinal epithelial cells from hypothyroid rats.
    Molinero P; Calvo JR; Jimenez J; Goberna R; Guerrero JM
    Biochem Biophys Res Commun; 1989 Jul; 162(2):701-7. PubMed ID: 2547371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vasoactive intestinal polypeptide regulates barrier function via mast cells in human intestinal follicle-associated epithelium and during stress in rats.
    Keita AV; Carlsson AH; Cigéhn M; Ericson AC; McKay DM; Söderholm JD
    Neurogastroenterol Motil; 2013 Jun; 25(6):e406-17. PubMed ID: 23600853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
    Gespach C; Bawab W; de Cremoux P; Calvo F
    Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vasoactive intestinal polypeptide and alpha 2-adrenoceptor agonists regulate adenosine 3',5'-monophosphate accumulation and melatonin release in chick pineal cell cultures.
    Pratt BL; Takahashi JS
    Endocrinology; 1989 Nov; 125(5):2375-84. PubMed ID: 2477231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart.
    Sawmiller DR; Henning RJ; Cuevas J; Dehaven WI; Vesely DL
    Neuropeptides; 2004 Oct; 38(5):289-97. PubMed ID: 15464194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of vasoactive intestinal peptide-mediated protein phosphorylation in human lymphoblasts and colonic epithelial cells.
    O'Dorisio MS; Campolito LB
    Mol Immunol; 1989 Jun; 26(6):583-90. PubMed ID: 2770750
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isolation and phenotypic characterization of colonic macrophages.
    Rogler G; Hausmann M; Vogl D; Aschenbrenner E; Andus T; Falk W; Andreesen R; Schölmerich J; Gross V
    Clin Exp Immunol; 1998 May; 112(2):205-15. PubMed ID: 9649182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. VIP stimulation of cAMP production in corneal endothelial cells in tissue and organ cultures.
    Koh SW; Yue BY
    Cornea; 2002 Apr; 21(3):270-4. PubMed ID: 11917175
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of Ca2+ current in canine colonic myocytes by cyclic nucleotide-dependent mechanisms.
    Koh SD; Sanders KM
    Am J Physiol; 1996 Sep; 271(3 Pt 1):C794-803. PubMed ID: 8843708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vasoactive intestinal polypeptide is a potent regulator of bile secretion from rat cholangiocytes.
    Cho WK; Boyer JL
    Gastroenterology; 1999 Aug; 117(2):420-8. PubMed ID: 10419925
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Secretin and vasoactive intestinal peptide are potent stimulants of cellular contraction and accumulation of cyclic AMP in rat ventricular cardiomyocytes.
    Bell D; McDermott BJ
    J Cardiovasc Pharmacol; 1994 Jun; 23(6):959-69. PubMed ID: 7523789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.